CD99 and synovial sarcoma: Tumour cells were immunoreactive for transducer-like enhancer of split 1 (TLE1) and cluster of differentiation 99 (CD99) with a score of 4+ and 3+, susceptible and specific for monophasic synovial sarcoma diagnosis.